Comment on: Hasselgren K, et al. ALPPS improves survival compared with TSH in patients affected of CRLM: Survival analysis from the randomized controlled trial LIGRO. Ann Surg. 2021;273(3):442-448 Correspondence

   

Authors:	Jarnagin, W. R.; Gönen, M.; D'Angelica, M. I.; Kingham, T. P.; Balachandran, V. P.; Wei, A. C.; Soares, K.; Drebin, J.
Title:	Comment on: Hasselgren K, et al. ALPPS improves survival compared with TSH in patients affected of CRLM: Survival analysis from the randomized controlled trial LIGRO. Ann Surg. 2021;273(3):442-448
Keywords:	controlled study; survival analysis; randomized controlled trial; surgery; hepatectomy; portal vein; thyrotropin; humans; human; hepatic portal vein
Journal Title:	Annals of Surgery
Volume:	276
Issue:	5
ISSN:	0003-4932
Publisher:	Lippincott Williams & Wilkins
Date Published:	2022-11-01
Start Page:	e631
End Page:	e632
Language:	English
DOI:	10.1097/sla.0000000000005262
PUBMED:	35129508
PROVIDER:	scopus
PMCID:	PMC9018892
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85139571975&doi=10.1097%2fSLA.0000000000005262&partnerID=40&md5=8d5485cacdb55b862ed236963e0024f6
Notes:	Article -- Export Date: 1 November 2022 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/199052